Lactuca capensis reverses memory deficits in Aβ1‐42‐induced an animal model of Alzheimer's disease
Open Access
- 16 August 2017
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 22 (1) , 111-122
Abstract
We investigated the neuropharmacological effects of the methanolic extract from Lactuca capensis Thunb. leaves (100 and 200 mg/kg) for 21 days on memory impairment in an Alzheimer's disease (AD) rat model produced by direct intraventricular delivery of amyloid‐β1‐42 (Aβ1‐42). Behavioural assays such as Y‐maze and radial arm maze test were used for assessing memory performance. Aβ1‐42 decreased cognitive performance in the behavioural tests which were ameliorated by pre‐treatment with the methanolic extract. Acetylcholinesterase activity and oxidant–antioxidant balance in the rat hippocampus were abnormally altered by Aβ1‐42 treatment while these deficits were recovered by pre‐treatment with the methanolic extract. In addition, rats were given Aβ1‐42 exhibited in the hippocampus decreased brain‐derived neurotrophic factor (BDNF) mRNA copy number and increased IL‐1β mRNA copy number which was reversed by the methanolic extract administration. These findings suggest that the methanolic extract could be a potent neuropharmacological agent against dementia via modulating cholinergic activity, increasing of BDNF levels and promoting antioxidant action in the rat hippocampus.Keywords
Funding Information
- Autoritatea Natională pentru Cercetare Stiintifică
This publication has 69 references indexed in Scilit:
- Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disordersFree Radical Biology and Medicine, 2017
- Lactuca sativa2017
- Neuroinflammation in Alzheimer's diseaseThe Lancet Neurology, 2015
- Effects of Lactuca sativa extract on exploratory behavior pattern, locomotor activity and anxiety in miceAsian Pacific Journal of Tropical Disease, 2012
- Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in ratsLife Sciences, 2002
- Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitroGlia, 2001
- Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's diseaseMolecular Brain Research, 2000
- β-Amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytesJournal of Neuroimmunology, 1996
- Glial cytokines in Alzheimer's disease: Review and pathogenic implicationsHuman Pathology, 1995
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961